Severe vivax malaria: A systematic review and meta-analysis of clinical studies since 1900

Malaria Journal

Volumn 13, Issue 1, 2014, Pages

  Rahimi, Bilal Ahmad ^a,b   Thakkinstian, Ammarin ^a   White, Nicholas J ^c,d   Sirivichayakul, Chukiat ^a   Dondorp, Arjen M ^c,d   Chokejindachai, Watcharee ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

^b Department of Pediatrics Faculty of Medicine Kandahar University   (Afghanistan)

^c MAHIDOL OXFORD TROPICAL MEDICINE RESEARCH UNIT   (Thailand)

^d UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Complication; Malaria; Meta analysis; Plasmodium vivax; Prevalence; Severe; Systematic review

Indexed keywords

CHLOROQUINE;

AFGHANISTAN; AFRICA; ANEMIA; ARTICLE; BANGLADESH; BRAIN MALARIA; CHINA; CLINICAL FEATURE; COMORBIDITY; DISEASE SEVERITY; DISEASE TRANSMISSION; DISSEMINATED INTRAVASCULAR CLOTTING; FATALITY; GEOGRAPHIC DISTRIBUTION; HEMOGLOBINURIA; HUMAN; HYPOGLYCEMIA; INDIA; INDONESIA; LIVER DYSFUNCTION; MADAGASCAR; MALARIA FALCIPARUM; META ANALYSIS; METABOLIC ACIDOSIS; MIDDLE EAST; MORTALITY; NONHUMAN; NORTH KOREA; PAKISTAN; PLASMODIUM VIVAX; PLASMODIUM VIVAX MALARIA; POLYMERASE CHAIN REACTION; PREVALENCE; RESPIRATORY FAILURE; SHOCK; SYSTEMATIC REVIEW; THROMBOCYTOPENIA; TONIC CLONIC SEIZURE; UNITED STATES; ADULT; CHILD; FEMALE; HEALTH; MALARIA, VIVAX; MALE; PATHOLOGY; PRESCHOOL CHILD; SURVIVAL ANALYSIS; TOPOGRAPHY;

ADULT; CHILD; CHILD, PRESCHOOL; FEMALE; GLOBAL HEALTH; HUMANS; MALARIA, VIVAX; MALE; PREVALENCE; SURVIVAL ANALYSIS; TOPOGRAPHY, MEDICAL;

EID: 84925255326     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-13-481     Document Type: Article

References (47)

1. Anstey NM, Russell B, Yeo TW, Price RN: The pathophysiology of vivax malaria. Trends Parasitol 2009, 25:220-227. 10.1016/j.pt.2009.02.003
2. Guerra CA, Howes RE, Patil AP, Gething PW, Van Boeckel TP, Temperley WH, Kabaria CW, Tatem AJ, Manh BH, Elyazar IR, Baird JK, Snow RW, Hay SI: The international limits and population at risk of Plasmodium vivax transmission in 2009. PLoS Negl Trop Dis 2010, 4:e774. 10.1371/journal.pntd.0000774
3. Galinski MR, Barnwell JW: Plasmodium vivax: who cares? Malar J 2008, 7:S9. 10.1186/1475-2875-7-S1-S9
4. Price RN, Tjitra E, Guerra CA, Yeung S, White NJ, Anstey NM: Vivax malaria: neglected and not benign. Am J Trop Med Hyg 2007, 77:79-87.
5. Gething PW, Elyazar IRF, Moyes CL, Smith DL, Battle KE, Guerra CA, Patil AP, Tatem AJ, Howes RE, Myers MF, George DB, Horby P, Wertheim HF, Price RN, Jueller I, Baird JK, Hay SI: A long neglected world malaria map: Plasmodium vivax endemicity in 2010. PLoS Negl Trop Dis 2012, 6:e1814. 10.1371/journal.pntd.0001814
6. Swellengrebel NH, Buck A: Malaria in the Netherlands. Amsterdam: Scheltema & Holkema ltd; 1938.
7. Billings F, Post WE: Fatal malaria due to the tertian parasite. Trans Chicago Pathological Soc 1915, 9:209-215.
8. Boshes B: Neuropsychiatric manifestations during the course of malaria; experiences in the Mediterranean Theater in World War II. Arch Neurol Psychiatry 1947, 58:14-27. 10.1001/archneurpsyc.1947.02300300024003
9. Verma KC, Magotra ML: Vivax cerebral malaria in Jammu. Indian Pediatr 1976, 13:229-231.
10. Price JP: Pernicious malaria in children: a report of 24 cases. South Med J 1937, 30:901. 10.1097/00007611-193709000-00008
11. Dhayagude RG, Purandare NM: Autopsy study of cerebral malaria with reference to malarial granuloma. Arch Pathol 1943, 36:550-558.
12. Barcus MJ, Basri H, Picarima H, Manyakori C, Sekartuti, Elyazar I, Bangs MJ, Maguire JD, Baird JK: Demographic risk factors for severe and fatal vivax and falciparum malaria among hospital admissions in northeastern Indonesian Papua. Am J Trop Med Hyg 2007, 77:984-991.
13. Tjitra E, Anstey NM, Sugiarto P, Warikar N, Kenangalem E, Karyana M, Lampah DA, Price RN: Multidrug-resistant Plasmodium vivax associated with severe and fatal malaria: a prospective study in Papua, Indonesia. PLoS Med 2008, 5:e128. 10.1371/journal.pmed.0050128
14. Genton B, D'Acremont V, Rare L, Baea K, Reeder JC, Alpers MP, Muller I: Plasmodium vivax and mixed infections are associated with severe malaria in children: a prospective cohort study from Papua New Guinea. PLoS Med 2008, 5:e127. 10.1371/journal.pmed.0050127
15. Naha K, Dasari S, Prabhu M: Spectrum of complications associated with Plasmodium vivax infection in a tertiary hospital in South-Western India. Asian Pac J Trop Med 2012, 5:79-82. 10.1016/S1995-7645(11)60251-4
16. Limaye CS, Londhey VA, Nabar ST: The study of complications of vivax malaria in comparison with falciparum malaria in Mumbai. J Assoc Physicians India 2012, 60:15-18.
17. WHO: Guidelines for the Treatment of Malaria. 2nd edition. Geneva: World Health Organization; 2010.
18. Lampah DA, Yeo TW, Hardianto SO, Tjitra E, Kenangalem E, Sugiarto P, Price RN, Anstey NM: Coma associated with microscopy-diagnosed Plasmodium vivax: a prospective study in Papua, Indonesia. PLoS Negl Trop Dis 2011, 5:e1032. 10.1371/journal.pntd.0001032
19. Luxemburger C, Ricci F, Nosten F, Raimond D, Bathet S, White NJ: The epidemiology of severe malaria in an area of low transmission in Thailand. Trans R Soc Trop Med Hyg 1997, 91:256-262. 10.1016/S0035-9203(97)90066-3
20. Wattanagoon Y, Srivilairit S, Looareesuwan S, White NJ: Convulsions in childhood malaria. Trans R Soc Trop Med Hyg 1994, 88:426-428. 10.1016/0035-9203(94)90415-4
21. Fitz-Hugh T Jr, Pepper DS, Hopkins HO: The cerebral form of malaria. Bull US Army Med 1944, 83:39-48.
22. Gopinathan VP, Subramanian AR: Pernicious syndromes in Plasmodium infections. Med J Aust 1982, 2:568-572.
23. Pukrittayakamee S, Chantra A, Vanijanonta S, White NJ: Pulmonary oedema in vivax malaria. Trans R Soc Trop Med Hyg 1998, 92:421-422. 10.1016/S0035-9203(98)91075-6
24. Rieckmann KH, Davis DR, Hutton DC: Plasmodium vivax resistance to chloroquine? Lancet 1989, 2:1183-1184.
25. Baird JK, Basri H, Purnomo, Bangs MJ, Subianto B, Patchen LC, Hoffman SL: Resistance to chloroquine by Plasmodium vivax in Irian Jaya, Indonesia. Am J Trop Med Hyg 1991, 44:547-552.
26. Schuurkamp GJ, Spicer PE, Kereu RK, Bulungol PK, Rieckmann KH: Chloroquine-resistant Plasmodium vivax in Papua New Guinea. Trans R Soc Trop Med Hyg 1992, 86:121-122. 10.1016/0035-9203(92)90531-G
27. de Santana Filho FS, Arcanjo AR, Chehuan YM, Costa MR, Martinez-Espinosa FE, Vieira JL, Barbosa M, Alecrim WD, Alecrim M: Chloroquine-resistant Plasmodium vivax, Brazilian Amazon. Emerg Infect Dis 2007, 13:1125-1126. 10.3201/eid1307.061386
28. Valecha N, Joshi H, Eapen A, Ravinderan J, Kumar A, Prajapati SK, Ringwald P: Therapeutic efficacy of chloroquine in Plasmodium vivax from areas with different epidemiological patterns in India and their Pvdhfr gene mutation pattern. Trans R Soc Trop Med Hyg 2006, 100:831-837. 10.1016/j.trstmh.2005.11.012
29. Garg M, Gopinathan N, Bodhe P, Kshirsagar NA: Vivax malaria resistant to chloroquine: case reports from Bombay. Trans R Soc Trop Med Hyg 1995, 89:656-657. 10.1016/0035-9203(95)90432-8
30. Mishra N, Singh JP, Srivastava B, Arora U, Shah NK, Ghosh SK, Bhatt RM, Sharma SK, Das MK, Kumar A, Anvikar AR, Kaitholia K, Gupta R, Sonal GS, Dhariwal AC, Valecha N: Monitoring antimalarial drug resistance in India via sentinel sites: outcomes and risk factors for treatment failure, 2009-2010. Bull World Health Organ 2012, 90:895-904.
31. Baird JK: Chloroquine resistance in Plasmodium vivax. Antimicrob Agents Chemother 2004, 48:4075-4083. 10.1128/AAC.48.11.4075-4083.2004
32. Beg MA, Sani N, Mehraj V, Jafri W, Khan MA, Malik A, Menezes E, Hussain R, Smego R Jr: Comparative features and outcomes of malaria at a tertiary care hospital in Karachi, Pakistan. Int J Infect Dis 2008, 12:37-42. 10.1016/j.ijid.2007.04.006
33. Leslie T, Mayan MI, Hasan MA, Safi MH, Klinkenberg E, Whitty CJ, Rowland M: Sulfadoxine-pyrimethamine, chlorproguanil-dapsone, or chloroquine for the treatment of Plasmodium vivax malaria in Afghanistan and Pakistan: a randomized controlled trial. JAMA 2007, 297:2201-2209. 10.1001/jama.297.20.2201
34. Melo GC, Reyes-Lecca RC, Vitor-Silva S, Monteiro WM, Martins M, Benzecry SG, Alecrim MG, Lacerda MV: Concurrent helminthic infection protects schoolchildren with Plasmodium vivax from anemia. PLoS One 2010, 5:e11206. 10.1371/journal.pone.0011206
35. Boel M, Carrara VI, Rijken M, Proux S, Nacher M, Pimanpanarak M, Paw MK, Moo O, Gay H, Bailey W, Singhasivanon P, White NJ, Nosten F, McGready R: Complex Interactions between soil-transmitted helminths and malaria in pregnant women on the Thai-Burmese border. PLoS Negl Trop Dis 2010, 4:e887. 10.1371/journal.pntd.0000887
36. Lampah DA, Yeo TW, Malloy M, Kenangalem E, Douglas NM, Ronaldo D, Sugiarto P, Simpson JA, Peospoprodjo JR, Anstey NM, Price RN: Severe thrombocytopenia: A risk factor for mortality in Papua, Indonesia. J Infect Dis 2014. jiu487v1-jiu487 [Epub ahead of print]
37. Moon SU, Lee HW, Kim JY, Na BK, Cho SH, Lin K, Sohn WM, Kim TS: High frequency of genetic diversity of Plasmodium vivax field isolates in Myanmar. Acta Trop 2009, 109:30-36. 10.1016/j.actatropica.2008.09.006
38. Zhong D, Bonizzoni M, Zhou G, Wang G, Chen B, Vardo-Zalik A, Cui L, Yan G, Zheng B: Genetic diversity of Plasmodium vivax malaria in China and Myanmar. Infect Genet Evol 2011, 11:1419-1425. 10.1016/j.meegid.2011.05.009
39. Looareesuwan S, White NJ, Chittamas S, Bunnag D, Harinasuta T: High rate of Plasmodium vivax relapse following treatment of falciparum malaria in Thailand. Lancet 1987, 2:1052-1055.
40. Mayxay M, Pukrittayakamee S, Newton PN, White NJ: Mixed-species malaria infections in humans. Trends Parasitol 2004, 20:233-240. 10.1016/j.pt.2004.03.006
41. Douglas NM, Nosten F, Ashley EA, Phaiphun L, van Vugt M, Singhasivanon P, White NJ, Price RN: Plasmodium vivax recurrence following falciparum and mixed species malaria: risk factors and effect of antimalarial kinetics. Clin Infect Dis 2011, 52:612-620. 10.1093/cid/ciq249
42. Shanks GD, White NJ: The activation of vivax malaria hypnozoites by infectious diseases. Lancet Infect Dis 2013, 13:900-906. 10.1016/S1473-3099(13)70095-1
43. Sharma A, Khanduri U: How benign is benign tertian malaria? J Vector Borne Dis 2009, 46:141-144.
44. Mehmood A, Ejaz K, Ahmed T: Severity of Plasmodium vivax malaria in Karachi: a cross-sectional study. J Infect Dev Ctries 2012, 6:664-670.
45. Manning L, Laman M, Rosanas-Urgell A, Michon P, Aipit S, Bona C, Siba P, Mueller I, Davis TM: Severe anemia in papua new guinean children from a malaria-endemic area: a case-control etiologic study. PLoS Negl Trop Dis 2012, 6:e1972. 10.1371/journal.pntd.0001972
46. Lacerda MV, Mourao MP, Alexandre MA, Siqueira AM, Magalhaes BM, Martinez-Espinosa FE, Santana Filho FS, Brasil P, Ventura AM, Tada MS, Couto VS, Silva AR, Silva RS, Alecrim MG: Understanding the clinical spectrum of complicated Plasmodium vivax malaria: a systematic review on the contributions of the Brazilian literature. Malar J 2012, 11:12. 10.1186/1475-2875-11-12
47. Baird JK: Evidence and implications of mortality associated with acute Plasmodium vivax malaria. Clin Microbiol Rev 2013, 26:36-57. 10.1128/CMR.00074-12